Wastewater treatment plants that accept discharges from pharmaceutical manufacturing facilities send “substantially” higher concentrations of medicines into rivers and streams than treatment plants that do not take these discharges, according to the first study to examine the issue across the U.S.

In reaching their conclusion, the study authors compared effluent — which is wastewater that is sent into rivers and other natural bodies of water — from 13 treatment plants that took pharmaceutical discharges and six plants that did not. They examined plants scattered among rural and urban locations around the country in order to compare plant sizes, varying climates, and technology used for treating wastewater.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy